drugset / Trial / NCT06216535

Escitalopram in Asthma Patients With Frequent Exacerbation

NCT06216535

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), such as escitalopram are widely used for mood and anxiety disorders. However, they have also been explored, with promising findings, for a variety of disorders outside of psychiatry. Clinical studies of SSRIs in depressed people with asthma were associated with decreased asthma exacerbations and improvement in asthma control. In this study, the number of asthma exacerbations will be assessed as the primary outcome measure in patients using escitalopram vs. placebo.

Timeline

Start
2025-05-19
Primary completion
2028-12-01
Completion
2029-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Escitalopram Small molecule 20 mg Oral

Indications